CLINICAL_TRIALS
trial_result
· 2017-04-04
Clinical Trial Update: Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
Summary
Phase 2 trial update reporting results for ziv-aflibercept in patients with metastatic or unresectable kidney cancer; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04